MICHAEL DONAHOE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations

Phase 1

Completed

Conditions: IPF

Interventions: Drug: Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids

First Posted Date: 2010-12-24

Last Posted Date: 2018-03-14

Lead Sponsor: Michael Donahoe

Target Recruit Count: 9

Registration Number: NCT01266317

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Oral Cyclosporine in Chronic Obstructive Pulmonary Disease

Phase 1

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Cyclosporine
Drug: Placebo

First Posted Date: 2009-09-10

Last Posted Date: 2018-05-09

Lead Sponsor: Michael Donahoe

Target Recruit Count: 43

Registration Number: NCT00974142

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy